From: Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker
 | ueRA | Healthy controls |
---|---|---|
Number | 43 | 14 |
Female (n (%)) | 30 (69.7) | 9 (64.2) |
Age (years) a,b,c | 61 (22–78) | 62.5 (35–72) |
Symptom duration (months) a,b,d | 6 (2–23) | ND |
CRP (mg/L) a,b | 9.1 (0.3–152) | ND |
ESR (mm/hour) a,b | 26 (5–108) | ND |
Swollen joint count of 66 a,b | 11 (2–30) | ND |
Tender joint count of 68 a,b | 14 (3–47) | ND |
Swollen joint count of 28 a,b | 9 (2–22) | ND |
Tender joint count of 28 a,b | 9 (0–27) | ND |
DAS28-CRP a,b | 5.1 (2.7–8) | ND |
DAS28-ESR a,b | 5.3 (2.6–8.4) | ND |
CDAI a,b | 28.1 (11.8–62.1) | ND |
ACPA ≥20 IU/ml (n (%)) | 34 (79) | ND |
RF ≥20 IU/ml (n (%)) | 33 (77) | ND |
ACPA ≥20 IU/ml + RF ≥20 IU/ml (n (%)) | 30 (70) | ND |
ACPA <20 IU/ml + RF <20 IU/ml (n (%)) | 5 (12) | ND |